Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

PHAT Stock Annual Income Statement. Download in Excel

Phathom Pharmaceuticals Inc. logo

Phathom Pharmaceuticals Inc.

Sector: Manufacturing   

Industry: Medicinal and Botanical Manufacturing

15.28
 
USD
  
0.19
  
(1.26%)
Previous close: 15.09  Open: 15.13  Bid: 14.77  Ask: 15.28
52 week range    
6.07   
   19.71
Mkt Cap: 1,125 M  Avg Vol (90 Days): 979,521
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Tuesday 15th October 2024

Stock Rankings

43
MarketXLS Rank
40
Value
53
Technical
36
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

PHAT Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-3.88-3.89-5.05-3.93
Basic EPS total-3.88-3.89-5.05-3.93
Basic weighted shares outstanding11 M33 M37 M39 M51 M
Cost of sales167000.0
Depreciation-8000.0300000.0500000.0600000.0600000.0
DepreciationAndAmortization-8000.0300000.0500000.0600000.0600000.0
Diluted EPS total-22.45-3.88-3.89-5.05-3.93
Diluted normalized net income/share-22.45-5.05-3.93
Diluted weighted shares outstanding11 M33 M37 M39 M51 M
GeneralAndAdministrativeExpense7 M28 M63 M101 M118 M
Gross operating profit515000.0
Income before tax-255 M-129 M-144 M-198 M-202 M
Income taxes-55000.0-68000.0-4000.0-4 M
Interest income-48 M1 M41000.02 M8 M
InterestExpenseNonOperating4 M5 M7 M27 M42 M
MiscOtherSpecialCharges-96 M87000.0-2 M-110000.0-188000.0
Net income from total operations-255 M-129 M-144 M-198 M-202 M
NetIncomeCommonStockholders-255 M-129 M-144 M-198 M-202 M
NetIncomeContinuousOperations-255 M-129 M-144 M-198 M-202 M
NetNonOperatingInterestIncomeExpense-53 M-3 M-7 M-25 M-34 M
Normalized income-144 M-206 M
Operating income-106 M-126 M-135 M-172 M-167 M
Operating income before depreciation (EBITDA)-251 M-124 M-137 M-170 M-159 M
OperatingExpense106 M126 M135 M172 M168 M
Other income net96 M-87000.02 M110000.0-188000.0
OtherGandA7 M28 M63 M101 M118 M
OtherOperatingExpenses79 M-762000.0-702000.0-623000.0-632000.0
Research & development expense20 M98 M72 M71 M50 M
ResearchExpense20 M98 M72 M71 M50 M
SalariesAndWages-406000.0
Selling Gen & administrative expense7 M28 M63 M101 M118 M
Total Income available for interest expense (EBIT)-251 M-124 M-137 M-170 M-160 M
Total common shares outstanding29 M31 M32 M42 M58 M
Total net income-255 M-129 M-144 M-198 M-202 M
Total ordinary shares60 M60 M60 M60 M60 M
Total revenues682000.0
TotalExpenses106 M126 M135 M172 M168 M
TotalRevenue682000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University